Paper41545969
Educational and regional differences in population-based incidence and survival of primary central nervous system lymphoma in Finland.
Ojala E and 6 others. BMC Cancer, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Educational and regional differences in population-based incidence and survival of primary central nervous system lymphoma in Finland. Papers, record 41545969. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41545969
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Educational and regional differences in population-based incidence and survival of primary central nervous system lymphoma in Finland.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Central Nervous System Neoplasms | Major topic |
| Educational Status | Major topic |
| Lymphoma, Large B-Cell, Diffuse | Major topic |
| Lymphoma | Major topic |
| Humans | |
| Finland | |
| Female | |
| Incidence | |
| Male | |
| Middle Aged | |
| Aged | |
| Registries | |
| Adult | |
| Survival Rate | |
| Aged, 80 and over | |
| Young Adult | |
| Adolescent |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29527660 | Impact of socioeconomic status on survival for patients with anal cancer. | Cancer | 2018 | https://conductscience.org/library/papers/29527660 | PubMed |
| 2 | 35347005 | The Trend of Combined Modality Treatment and its Outcomes in Elderly Patients With Primary CNS Lymphoma: A 12-year Population-based Analysis Using Propensity Score. | Anticancer Res | 2022 | https://conductscience.org/library/papers/35347005 | PubMed |
| 3 | 9486590 | Risk factors for primary central nervous system lymphoma: a case-control study. | Cancer | 1998 | https://conductscience.org/library/papers/9486590 | PubMed |
| 4 | 33499081 | Changing Incidence and Survival of Primary Central Nervous System Lymphoma in Australia: A 33-Year National Population-Based Study. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33499081 | PubMed |
| 5 | 28450731 | Improved survival in primary central nervous system lymphoma up to age 70 only: a population-based study on incidence, primary treatment and survival in the Netherlands, 1989-2015. | Leukemia | 2017 | https://conductscience.org/library/papers/28450731 | PubMed |
| 6 | 21915121 | Age, gender, and racial differences in incidence and survival in primary CNS lymphoma. | Br J Cancer | 2011 | https://conductscience.org/library/papers/21915121 | PubMed |
| 7 | 36369792 | Socioeconomic inequality in cancer in the Nordic countries. A systematic review. | Acta Oncol | 2022 | https://conductscience.org/library/papers/36369792 | PubMed |
| 8 | 17084198 | Rising incidence of primary central nervous system lymphoma in Kumamoto, Japan. | Surg Neurol | 2006 | https://conductscience.org/library/papers/17084198 | PubMed |
| 9 | 40438704 | Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System-Outcomes in Finland: A Nationwide Population-Based Study. | EJHaem | 2025 | https://conductscience.org/library/papers/40438704 | PubMed |
| 10 | 27018254 | Trends in primary central nervous system lymphoma incidence and survival in the U.S. | Br J Haematol | 2016 | https://conductscience.org/library/papers/27018254 | PubMed |
| 11 | 29296804 | Therapy and outcomes of primary central nervous system lymphoma in the United States: analysis of the National Cancer Database. | Blood Adv | 2016 | https://conductscience.org/library/papers/29296804 | PubMed |
| 12 | 17116938 | Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. | J Clin Oncol | 2006 | https://conductscience.org/library/papers/17116938 | PubMed |
| 13 | 36091170 | Socioeconomic deprivation and survival outcomes in primary central nervous system lymphomas. | Front Oncol | 2022 | https://conductscience.org/library/papers/36091170 | PubMed |
| 14 | 32552300 | Variation in cancer survival between hospital districts and within them in Finland. | Acta Oncol | 2020 | https://conductscience.org/library/papers/32552300 | PubMed |
| 15 | 33573146 | Epidemiology of Non-Hodgkin's Lymphoma. | Med Sci (Basel) | 2021 | https://conductscience.org/library/papers/33573146 | PubMed |
| 16 | 35241020 | Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis. | BMC Cancer | 2022 | https://conductscience.org/library/papers/35241020 | PubMed |
| 17 | 28983970 | Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013. | Eur J Haematol | 2018 | https://conductscience.org/library/papers/28983970 | PubMed |
| 18 | 31377920 | Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation. | J Neurooncol | 2019 | https://conductscience.org/library/papers/31377920 | PubMed |
| 19 | 21145729 | Socioeconomic inequalities in prognostic markers of non-Hodgkin lymphoma: analysis of a national clinical database. | Eur J Cancer | 2011 | https://conductscience.org/library/papers/21145729 | PubMed |
| 20 | 22315055 | Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark--a nationwide study. | Br J Cancer | 2012 | https://conductscience.org/library/papers/22315055 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41545969
GET https://conductscience.org/api/papers/v1/41545969/references?page=2